Nick Devoogdt,
Professor,
Free University Brussels (VUB)
Nick Devoogdt is trained as a molecular biologist at the Free University Brussels where he obtained his PhD in cancer genetics and immunology in 2004. After a postdoc at the National Cancer Institute in Bethesda, USA, he returned to Belgium for a series of postdoc positions in cancer biology, nanobody technology and nuclear medicine. In 2013 he became associate professor and full professor in 2016. In 2014 he co-founded the spin-off company Camel-IDS, where he currently also holds the position of CSO.
|
|
Antibody Engineering and Diagnostic Imaging at the Forefront of Targeted TherapiesTuesday, 7 March 2017 at 09:30  Add to Calendar ▼2017-03-07 13:59:002017-03-07 14:59:00Europe/LondonSession 4SELECTBIOenquiries@selectbiosciences.comThe application of nanobodies as tracers and therapeutic vehicles for nuclear medicine in a range of pathologies will be presented, including compound discovery, preclinical animal testing and clinical translation.
|
.gif){kind=logo}
